Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerio Nardone

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
Journal of Personalized Medicine|October 27, 2022
Non-Oncological Radiotherapy: A Review of Modern ApproachesValerio Nardone, Emma D'Ippolito, Roberta Grassi, et al.
Molecular and Clinical Oncology|July 11, 2019
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumabRocco Giannicola, Graziella D'Arrigo, Cirino Botta, et al.
Journal of Cancer Research and Clinical Oncology|February 1, 2019
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistanceFrancesco Marampon, Silvia Codenotti, Francesca Megiorni, et al.
Oncotarget|May 15, 2018
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccinePierpaolo Correale, Cirino Botta, Nicoletta Staropoli, et al.
La Radiologia Medica|February 14, 2023
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a reviewValerio Nardone, Caterina Romeo, Emma D'Ippolito, et al.
Clinical Drug Investigation|June 17, 2024
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 TrialErika Martinelli, Davide Ciardiello, Giulia Martini, et al.
Journal of Personalized Medicine|November 24, 2022
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and ShadowsMarco Montella, Giovanni Ciani, Vincenza Granata, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
The Role of Artificial Intelligence on Tumor Boards: Perspectives from Surgeons, Medical Oncologists and Radiation OncologistsValerio Nardone, Federica Marmorino, Marco Maria Germani, et al.
Histopathology|March 13, 2026
High prevalence of loss of Claudin-18 expression in invasive non-mucinous lung adenocarcinoma: Potential diagnostic implications in routine practiceStefano Lucà, Marco Montella, Mario Fordellone, et al.
Tomography (Ann Arbor, Mich.)|July 27, 2022
Secondary Complications in COVID-19 Patients: A Case SeriesMaria Paola Belfiore, Gaetano Maria Russo, Luigi Gallo, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Journal of Personalized Medicine|October 27, 2022
Non-Oncological Radiotherapy: A Review of Modern ApproachesValerio Nardone, Emma D'Ippolito, Roberta Grassi, et al.
Molecular and Clinical Oncology|July 11, 2019
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumabRocco Giannicola, Graziella D'Arrigo, Cirino Botta, et al.
Journal of Cancer Research and Clinical Oncology|February 1, 2019
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistanceFrancesco Marampon, Silvia Codenotti, Francesca Megiorni, et al.
Oncotarget|May 15, 2018
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccinePierpaolo Correale, Cirino Botta, Nicoletta Staropoli, et al.
La Radiologia Medica|February 14, 2023
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a reviewValerio Nardone, Caterina Romeo, Emma D'Ippolito, et al.
Clinical Drug Investigation|June 17, 2024
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 TrialErika Martinelli, Davide Ciardiello, Giulia Martini, et al.
Journal of Personalized Medicine|November 24, 2022
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and ShadowsMarco Montella, Giovanni Ciani, Vincenza Granata, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
The Role of Artificial Intelligence on Tumor Boards: Perspectives from Surgeons, Medical Oncologists and Radiation OncologistsValerio Nardone, Federica Marmorino, Marco Maria Germani, et al.
Histopathology|March 13, 2026
High prevalence of loss of Claudin-18 expression in invasive non-mucinous lung adenocarcinoma: Potential diagnostic implications in routine practiceStefano Lucà, Marco Montella, Mario Fordellone, et al.
Tomography (Ann Arbor, Mich.)|July 27, 2022
Secondary Complications in COVID-19 Patients: A Case SeriesMaria Paola Belfiore, Gaetano Maria Russo, Luigi Gallo, et al.
Pageof 14